In a 24/7 Biopharma roundtable in the run-up to DCAT Week 2026, thought leaders across the industry comment on the mood of the outsourcing market, to what extent geopolitical pressure reshape sourcing decisions, the most meaninful growth opportunities to come, and more.
Kevin Sharp, Executive Vice President, Head of Sales and Operations; Ryan Lee, Senior Director of Sales and Operations; and Minjeong Seong, Director of Market Intelligence share their thoughts.
In this article, we share perspectives on:
✅ Evolving CDMO selection criteria
✅ The rise of regionalization and dual sourcing
✅ Balancing cost, resilience, and innovation
✅ Where the next wave of growth will emerge
In a 24/7 Biopharma roundtable in the run-up to DCAT Week 2026, thought leaders across the industry comment on the mood of the outsourcing market, to what extent geopolitical pressure reshape sourcing decisions, the most meaninful growth opportunities to come, and more.
Kevin Sharp, Executive Vice President, Head of Sales and Operations; Ryan Lee, Senior Director of Sales and Operations; and Minjeong Seong, Director of Market Intelligence share their thoughts.
In this article, we share perspectives on:
✅ Evolving CDMO selection criteria
✅ The rise of regionalization and dual sourcing
✅ Balancing cost, resilience, and innovation
✅ Where the next wave of growth will emerge
Share article
Related Content